The Boston-based dog genetics company raised $75 million in Series B funding in what the company is calling “the biggest Series B for a pet startup to date.” SoftBank Vision Fund 2 was the lead investor and was joined by existing investors F-Prime Capital, SV Angel, Slow Ventures, Freestyle Capital and Third Kind Venture Capital.
Read MoreSince its inception, Eterneva has seen triple-digit growth in sales — including in 2020, when it more than doubled its revenue, according to CEO and co-founder Adelle Archer. And today, the company is announcing an “oversubscribed” $10. million Series A funding round led by Tiger Management with participation from Goodwater Capital, Capstar Ventures, NextCoast Ventures and Dallas billionaire Mark Cuban. (For the unacquainted, Tiger Management is the hedge fund and family office of Julian Robertson from which Tiger Global Management descended.)
Read MoreSending a VC your Cold Deck PDF maybe worked in 1999 - but it doesn’t work today. Here’s what to do instead.
Read MoreHere’s an interview with Unicorn client Nancy Briefs, CEO of AltrixBio, who successfully raised $1.5M during COVID using her biotech pitch deck.
Read More
